APO 150
Pill imprint APO 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Nizatidine Images
- Imprint:
-
APO
150 - Strength:
- 150 mg
- Color:
- White & Yellow
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0230
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55045-3748 | Dispensing Solutions Inc. (repackager) |
| 55887-0153 | Diversified Healthcare Services Inc (repackager) |
| 23490-6010 | Palmetto State Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Nizatidine resources
- Nizatidine (Wolters Kluwer)
- Nizatidine Solution (Wolters Kluwer)
- nizatidine (Cerner Multum)
- Nizatidine (AHFS DI)
- Nizatidine (FDA)
- Nizatidine Solution (FDA)
- Nizatidine (Wolters Kluwer)
Search Again
